当前位置：   首页 > 需求大厅

 >  生产研发 

 >  其他 

2类全套申报资料模板   [更多]

全套模板   [更多]

全套申报模板资料   [更多]

红曲霉在食物中的应用已有千年的历史.近年来,由于它能够生成多种生理活性物质而备受各国的关注.然而,目前发现多种长期应用于工业生产的红曲霉在产生色素和生理活性物质的同时,还能分泌一种真菌毒素-桔霉素.桔霉素主要作用的靶器官是肾脏,它不仅可以致畸、导致肿瘤的发生,而且可以诱发突变.，需要新技术在红酒酿造过程降低桔霉素含量及测定方法。   [更多]

至少包含目录及管理制度(项目管理、数据，记录，仪器，物料，计算机等)   [更多]

需要一位可以开具处方药的医生，因为研发需要购买原研。具体详谈。   [更多]

求购标准：预充式冲管注射器YZB/国 0829-2013、YZBUSA 1273-2013标准，字迹清晰   [更多]

理论分析一种材料，能有明显区分其与丙酮或水（潮湿）的物理作用。如膨胀，收缩，卷曲，等等。此材料不限于纤维，膜剂或织物。 “请于2016年5月23日之前将稿件上传到：https://www.innocentive.com/ar/challenge/9933858 “ Challenge Overview Many materials (usually polymers) change shape when exposed to acetone (ketones in general) but also have a large affinity for moisture as well. It would be very difficult to attribute physical changes to acetone or water if both were present. The Seeker is looking for materials and associated processes that produce an observable physical change to the substrate upon exposure to acetone. The material should not have the same effect when exposed to moisture so the two can be differentiated. The effect should be reversible and the rate of absorb/desorb should be similar. This is a Theoretical Challenge that requires only a written proposal to be submitted. The Challenge award will be contingent upon theoretical evaluation of the proposal by the Seeker. To receive an award, the Solvers will have to transfer to the Seeker their exclusive Intellectual Property (IP) rightsto the solution. However, the Seeker will be willing to consider a licensing agreement for a partial award if exclusive IP cannot be transferred by the Solver. Submissions to this Challenge must be received by 11:59 PM (US Eastern Time) on May 23, 2016. Late submissions will not be considered.   [更多]

求购COC预灌封注射器，数量10只，须肖特公司出品。   [更多]

Boehringer Ingelheim公司寻找一种有机小分子，能够安全使用，没有生物活性，或非常温和的生物活性，能够显示细胞的渗透性，并且在长期口服的情况下能够达到高血药浓度。 有机小分子常见于：药物化学，内科医师，配方科学（盖仑制剂），药剂学，药理学等领域。 有机小分子不常见于 ：动物医疗，农业科学，食物化学，营养学，化妆品，或其他等领域。 投标截止时期2016年6月26日, 投标网址：https://www.innocentive.com/ar/projectRoom/index?challenge=9933854 Seeking Safe Drug-like Small Organic Molecules for Human Use with Negligible Biological Effects TAGS: Chemistry, Life Sciences, Food/Agriculture, Royal Society of Chemistry, Ideation AWARD: $20,000 USD | DEADLINE: 6/26/16 | ACTIVE SOLVERS: 106 | POSTED: 4/27/16 Boehringer Ingelheim (The Seeker) is interested in small organic molecules that are safe for human use, show no, or very mild, biological activity, display cell permeability, and achieve high concentrations (µM) in the plasma when chronically administered via the oral route. This is an Ideation Challenge with a guaranteed award for at least one submitted solution. Source: InnoCentive Challenge ID: 9933854 Sign Agreement For This Challenge By electronically signing the agreement below, you are indicating your intention to view the details of this specific InnoCentive Challenge. Viewing the Challenge Details does not obligate you to perform any work on this challenge. Print this Agreement for your records InnoCentive Ideation Challenge-Specific Agreement Please Read This Carefully! You and InnoCentive are agreeing to a Challenge-Specific Solver Agreement for this particular InnoCentive Ideation Challenge only. The Seeker for this InnoCentive Challenge has required that you accept these special terms, so please take the time to understand them. If you click \\"I agree\\" and proceed to the Project Room for this InnoCentive Challenge, this Challenge-Specific Agreement (\\"CSA\\") will be a valid and binding agreement between you and InnoCentive and in addition to the existing Terms of Use for all purposes relating to this InnoCentive Challenge. Please print and keep a copy of this CSA. No provisions you may have   [更多]